CompletedN/AOther

KETODEX for Emergence Delirium in Children Undergoing Outpatient Strabismus Surgery

Sponsored by Ochsner Health System

NCT ID
NCT03779282
Target Enrollment
90 participants
Start Date
2018-02-15
Est. Completion
2018-09-15

About This Study

Strabismus surgery for children is a very common procedure, with a high incidence of emergence delerium in the recovery room. A combination of intravenous ketamine/dexmedetomidine, or ketodex, has been previously shown to reduce emergence delerium in children undergoing adenotonsillectomy. Here, we study its application in strabismus surgery.

Conditions Studied

Emergence DeliriumStrabismus

Interventions

  • Dexmedetomidine

Eligibility

Age:N/A - 18 Years
Healthy Volunteers:Yes
View full eligibility criteria
Inclusion Criteria:

* ASA I/II children undergoing outpatient strabismus surgery

Exclusion Criteria:

* anything not meeting the above

Study Locations (1)

Ochsner Main Campus
Jefferson, Louisiana, United States

This trial is not recruiting

This study has completed enrollment. Check back for results or find similar trials.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source